Sequenom, Inc (NASDAQ:SQNM) summarizes their mission as improving healthcare through revolutionary genetic analysis solutions. They operate in two business segments: Diagnostic Services and Genetic Analysis. Driving my investment thesis in Sequenom is the disruptive innovation occurring in genomic personalized medicine, which is revolutionizing the healthcare industry at a breathtaking pace. Nowhere is this more visible than in the nascent Noninvasive Prenatal Testing ("NIPT") market, in which Sequenom and a few other companies are quite literally changing prenatal care at an unprecedented rate. That these fundamental shifts are occurring so rapidly has compounded existing investor uncertainty caused by a lack of financial visibility. It is my contention that these clouds are beginning to dissipate, revealing a...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|